Skip to content

Irinotecan EP Impurity H

Irinotecan EP Impurity H

Product Description
CAT No.
ALN-I010037
CAS No.
1608617-71-5
Mol. F.
C32H36N4O6
Mol. Wt.
572.7
Stock
Please Inquire
RFQ
Chemical Name : (4S)-11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl 1,4′-bipiperidine-1′-carboxylate (as per EP)
Smiles : O=C(N1CCC(N2CCCCC2)CC1)OC3=CC=C4N=C5C(CN6C(C(COC(C7(O)C)=O)=C7C=C65)=O)=C(CC)C4=C3.Cl
Inchi : InChI=1/C32H36N4O6.ClH/c1-3-21-22-15-20(42-31(39)35-13-9-19(10-14-35)34-11-5-4-6-12-34)7-8-26(22)33-28-23(21)17-36-27(28)16-25-24(29(36)37)18-41-30(38)32(25,2)40;/h7-8,15-16,19,40H,3-6,9-14,17-18H2,1-2H3;1H
Synonym : 4-Methyl Irinotecan Analogue (EP)

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K.nFrom International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Method development, validation and forced degradation studies of Irinotecan in bulk and pharmaceutical dosage form

By Swathi, Koduru; Farooqui, Tahmeena; Muntaha, Sidra Tul; Ayesha, Syeda Amtul; Shama, Syeda; Siddiqui, Sarah Imam – From World Journal of Pharmacy and Pharmaceutical Sciences (2018), 7(8), 996-1009

Request For Quotation